The federal government has warned civil servants that indolence and incompetence will no longer be tolerated in public service.
Beneficial clinical responses observed with EO2463 monotherapy already at 6 weeks and complete response rate of 78% in patients treated with EO2463 upon addition of lenalidomide ± rituximab - EO2463 r ...
During a Case-Based Roundtable® event, Sumanta K. Pal, MD, moderated a discussion on quality of life data and experiences ...
This is the second accelerated approval the FDA has granted to Bristol Myers Squibb’s chimeric antigen receptor T-cell ...
PRESS RELEASEAB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL ...
TUESDAY, April 23, 2024 (HealthDay News) — Nearly one-quarter of patients show persistent early knee osteoarthritis (OA) symptoms six to 12 months after anterior cruciate ligament reconstruction (ACLR ...
The following is a summary of “Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity,” published in the April 2024 issue of Hematology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback